DGX vs. MDT

In the year-to-date period, DGX achieves a 16.31% return, which is significantly higher than MDT's 6.19% return. Over the past 10 years, DGX has outperformed MDT with an annualized return of 11.50%, while MDT has yielded a comparatively lower 3.65% annualized return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for Quest Diagnostics Incorporated (DGX) and Medtronic plc (MDT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current DGX Sharpe Ratio is 1.33, which is higher than the MDT Sharpe Ratio of 0.33. The chart below compares the historical Sharpe Ratios of DGX and MDT, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

DGX's dividend yield for the trailing twelve months is around 1.76%, less than MDT's 3.33% yield.

The maximum DGX drawdown since its inception was -49.46%, smaller than the maximum MDT drawdown of -57.63%. Use the drawdown chart below to compare losses from any high point for DGX and MDT. For additional features, visit the drawdowns tool.

Quest Diagnostics Incorporated (DGX) and Medtronic plc (MDT) have volatilities of 9.76% and 9.60%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.

This section allows you to compare key financial metrics between Quest Diagnostics Incorporated and Medtronic plc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.